ProjectStudie PACMEL: Paclitaxel +/- GSK1120212 or pazopanib in Melanoma - EudraCT No. 2011-002545-35
Basic data
Title:
Studie PACMEL: Paclitaxel +/- GSK1120212 or pazopanib in Melanoma - EudraCT No. 2011-002545-35
Duration:
01/12/2014 to 31/05/2017
Abstract / short description:
Randomised phase 2 study of paclitaxel with or without GSK1120212 orpazopanib in advanced wt BRAF melanoma
Involved staff
Managers
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine
Faculty of Medicine
Funders
Essen, Nordrhein-Westfalen, Germany